Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality goggles may calm chemotherapy patients

NCT ID NCT07152938

Symptom relief Sponsor: Arab American University (Palestine) Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether using augmented virtual reality (AVR) during chemotherapy can help reduce pain, stress, and anxiety while boosting self-confidence. 150 adult cancer patients in the West Bank were split into two groups: one received standard care, and the other used AVR before and during their chemo session. Researchers measured changes right after the session to see if AVR made a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
augmented virtual reality (AVR)
What this could lead to
If it works, this could offer a drug-free way to ease pain, stress, and anxiety during chemotherapy sessions.
What could go wrong
This is a small, completed study with only 150 patients, so results may not apply to everyone. The effects were measured right after the session, so long-term benefits are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

150 people

The number who actually took part.

Started

Jun 2023

Finished

Oct 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adult patients aged 18-60 years undergoing chemotherapy for breast or colon cancer. 2. Stage I or II cancer, as defined by the study protocol. 3. Manageable levels of pain, anxiety, and stress, appropriate for participation in the intervention. \- Exclusion Criteria: 1. Age over 60 years. 2. Cancer types other than breast or colon cancer. 3. Severe pain, anxiety, or stress that could interfere with participation or require intensive care beyond the study scope.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

agnosia anxiety disorder breast cancer breast neoplasm cancer colon carcinoma colonic neoplasm lymphoma neoplasm plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer (colon cancer, breast cancer, lymphoma, chronic lymphoma leukemia, multiple myeloma) Cancer and chemotherapy related anemia

Contacts and locations

Locations

  • AL-Watni governmental hospital

    Nablus, 00970, Palestinian Territories

  • Jenin governmental hospital

    Jenin, 00970, Palestinian Territories

  • Thabet Thabet governmental hospital

    Tulkarm, 00970, Palestinian Territories

More trials for these conditions

Other studies related to the condition(s) this trial covers.